8-K
Current Report
Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-18-000016
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading amrx-8kx5x16x2018.htm…